MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)

Update Il y a 4 ans
Reference: NCT00506077

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to determine the safety and effectiveness of an investigational drug MK0249 for the treatment of the cognitive impairment in patients with schizophrenia.


Inclusion criteria

  • Paranoid schizophrenia

Links